Sanara Medtech Stock

Sanara Medtech OCF Margin

The Operating Cash Flow Margin of Sanara Medtech (SMTI) as of Aug 15, 2026 is 6.58 %. In the previous year, Operating Cash Flow Margin was -0.03 % — a change of -24,083.68% (higher).

OCF Margin

6.58 %

YoY

-24,083.68%

Last updated:

Operating Cash Flow Margin of Sanara Medtech is 2026 6.58 % . Operating Cash Flow Margin of Sanara Medtech was 2025 -0.03 % . It decreases by -24,083.68% higher compared to the previous year.
Access this data via the Eulerpool API

Sanara Medtech Stock analysis

What does Sanara Medtech do? Sanara Medtech Inc is a leading company specializing in the development of innovative medical devices and solutions. The company is headquartered in Texas, USA and has experienced significant growth since its founding in 2014. Its areas of specialization include wound care, incontinence management, and dermatology. The history of Sanara Medtech Inc began in 2014 when a team of experienced medical technology experts founded the company. Leveraging their extensive industry knowledge and expertise, the team quickly identified a market niche and established themselves as a leading provider of innovative solutions. The business model of Sanara Medtech Inc is focused on developing medical devices and solutions that aim to improve the daily lives of patients and healthcare professionals. The company is committed to developing and manufacturing top-quality products that contribute to enhancing patient care and supporting healthcare professionals in their tasks. Sanara Medtech Inc offers a wide range of products tailored to the needs of patients and medical professionals. Its wound care products include wound dressings, wound healing ointments, and other specialized products for treating chronic and acute wounds. The incontinence management products include disposable and reusable incontinence products designed to improve the lives of individuals with incontinence issues. Dermatology products encompass a wide range of products for treating skin conditions such as psoriasis, eczema, and rosacea, to name a few. Another focus of Sanara Medtech Inc is collaborating with private and public healthcare facilities to ensure the availability of its products in hospitals, clinics, nursing homes, and other healthcare facilities. The company also offers training and educational programs for healthcare professionals to ensure proper product use. In summary, Sanara Medtech Inc is an innovative company specializing in the development of medical devices and solutions tailored to the needs of patients and healthcare professionals. Its goal is to develop top-quality products that contribute to the improvement of healthcare and enhance the lives of patients. With a wide range of products and a strong market presence, Sanara Medtech Inc is a leading force in the medical technology industry. Sanara Medtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanara Medtech stock

Operating Cash Flow Margin of Sanara Medtech is 6.58 % in 2026.

Operating Cash Flow Margin of Sanara Medtech changed from -0.03 % to 6.58 %, representing a -24,083.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Sanara Medtech since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Sanara Medtech with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Sanara Medtech

All Key Metrics — Sanara Medtech